SCHEMBL26038820

SCHEMBL26038820

CC(C)CC(C)(C(=O)OCCCCCCn1ccc(=O)n(C2CC2)c1=O)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26038799 0.86 DRD2 (0.34) —
SCHEMBL26038805 0.84 — —
SCHEMBL26038765 0.83 — —
SCHEMBL26038811 0.82 TNF (0.30) —
SCHEMBL26038792 0.82 CNR2 (0.33) —
SCHEMBL26037121 0.81 ALDH1A1 (0.32) —
SCHEMBL26037373 0.79 — —
SCHEMBL26037111 0.79 SLC6A2 (0.31) SLC6A2SLC6A4SLC6A3
SCHEMBL26036713 0.78 DUT (0.48) —
SCHEMBL26036709 0.78 DUT (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230273455-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230273455-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6A, PDE6D SLC6A2 4831/4885SLC6A4 4822/4885SLC6A3 4696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback